NW
GSK icon

Naviter Wealth’s GSK GSK Stock Holding History

Naviter Wealth’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.44M Buy
43,754
+1,682
+4% +$91.1K 0.3% 81
2025
Q4 		$2.08M Sell
42,072
-8,253
-16% -$385K 0.27% 88
2025
Q3 		$2.19M Buy
50,325
+1,473
+3% +$57.5K 0.26% 99
2025
Q2 		$1.9M Buy
48,852
+2,178
+5% +$83.2K 0.23% 115
2025
Q1 		$1.83M Sell
46,674
-990
-2% -$36.2K 0.22% 125
2024
Q4 		$1.63M Buy
47,664
+244
+0.5% +$8.78K 0.2% 133
2024
Q3 		$1.96M Sell
47,420
-241
-0.5% -$9.86K 0.27% 108
2024
Q2 		$1.85M Buy
47,661
+3,742
+9% +$157K 0.28% 106
2024
Q1 		$1.9M Sell
43,919
-829
-2% -$34.2K 0.31% 91
2023
Q4 		$1.67M Buy
44,748
+10,171
+29% +$365K 0.34% 82
2023
Q3 		$1.27M Buy
34,577
+2,312
+7% +$82.1K 0.31% 81
2023
Q2 		$1.16M Buy
32,265
+3,348
+12% +$120K 0.3% 88
2023
Q1 		$1.04M Sell
28,917
-4,918
-15% -$172K 0.36% 79
2022
Q4 		$1.17M Buy
33,835
+3,182
+10% +$106K 0.32% 77
2022
Q3 		$906K Buy
30,653
+11,543
+60% +$437K 0.37% 58
2022
Q2 		$1.04M Buy
+19,110
New +$1.05M 0.43% 49

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Naviter Wealth's GSK Position: Q1 2026 in Review

Naviter Wealth increased its GSK (GSK) stake by 4% in Q1 2026, buying an estimated $91.1K and bringing the position to 43,754 shares worth $2.44M. The position accounts for 0.3% of the portfolio, ranked #81.

Naviter Wealth first reported a position in GSK in Q2 2022 and has held it in 16 quarters since. 1,033 funds tracked by Wall St. Rank hold GSK as of Q1 2026.

  • Naviter Wealth held 43,754 shares of GSK worth $2.44M as of Q1 2026.
  • Naviter Wealth bought 1,682 GSK shares in Q1 2026, an estimated $91.1K.
  • GSK made up 0.3% of Naviter Wealth's portfolio in Q1 2026, its #81 holding.
  • Naviter Wealth first reported a position in GSK in Q2 2022 and has held it in 16 quarters since.
  • 1,033 funds tracked by Wall St. Rank held GSK as of Q1 2026.

Based on Naviter Wealth's 13F filing for Q1 2026, filed 10 Apr 2026.